China NMPA Inspection - Hubei Langde Medical Technology Co., Ltd. - April 11, 2017

An unannounced inspection conducted by the Hubei Provincial Food and Drug Administration, detailed in a report published on April 11, 2017, revealed significant deficiencies at Hubei Langde Medical Technology Co., Ltd. The inspection found that the company's operations did not adhere to the essential requirements of the Good Manufacturing Practice for Medical Devices (GMP). Specifically, its quality management system was identified as having shortcomings, indicating a failure to maintain the necessary standards for medical device production and control. As a direct consequence of these findings, the Hubei Provincial Food and Drug Administration issued an official order to Hubei Langde Medical Technology Co., Ltd. The company is now mandated to address and rectify all identified deficiencies within a stipulated timeframe. This regulatory action underscores the importance of stringent adherence to quality and safety standards within the medical device manufacturing sector to ensure product integrity and public health. The National Medical Products Administration (NMPA) hosts the official report related to this regulatory enforcement action.